Cordance derived from REM sleep EEG as a biomarker for treatment response in depression - a naturalistic study after antidepressant medication

Journal of Psychiatric Research

Volumn 63, Issue , 2015, Pages 97-104

  Adamczyk, Marek ^a   Gazea, Mary ^a   Wollweber, Bastian ^a   Holsboer, Florian ^a   Dresler, Martin ^a   Steiger, Axel ^a   Pawlowski, Marcel ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antidepressants; Biomarker; Cordance; Depression; EEG; REM sleep

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPLE REUPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ELECTROENCEPHALOGRAM; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LATENT PERIOD; MALE; NATURALISTIC INQUIRY; OPEN STUDY; POLYSOMNOGRAPHY; PREFRONTAL THETA CORDANCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REM SLEEP; SLEEP TIME; SLOW WAVE SLEEP; TREATMENT OUTCOME; TREATMENT RESPONSE; ALGORITHM; ANALYSIS OF VARIANCE; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; FOURIER ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PROCEDURES; PSYCHOLOGICAL RATING SCALE; THETA RHYTHM;

ADULT; ALGORITHMS; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; DEPRESSION; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; FEMALE; FOURIER ANALYSIS; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SLEEP, REM; THETA RHYTHM; TREATMENT OUTCOME;

EID: 84926408437     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.02.007     Document Type: Article

References (44)

1. American Academy of Sleep Medicine Atechnologist's handbook for understanding and implementing the AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications 2009, AASM, Westchester, Illinois.
2. Asada H., Fukuda Y., Tsunoda S., Yamaguchi M., Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett 1999, 274:29-32.
3. Bares M., Brunovsky M., Kopecek M., Stopkova P., Novak T., Kozeny J., et al. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. JPsychiatr Res 2007, 41:319-325.
4. Bares M., Brunovsky M., Kopecek M., Novak T., Stopkova P., Kozeny J., et al. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry 2008, 23:350-355.
5. Bares M., Brunovsky M., Novak T., Kopecek M., Stopkova P., Sos P., et al. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol 2010, 20:459-466.
6. Bares M., Novak T., Brunovsky M., Kopecek M., Stopkova P., Krajca V., et al. The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study. JPsychiatric Res 2011, 46:219-225.
7. Braun A.R., Balkin T.J., Wesensten N.J., Carson R.E., Varga M., Baldwin P., et al. Regional cerebral blood flow throughout the sleep wake cycle-an (H2O)-O-15 PET study. Brain 1997, 120:1173-1197.
8. Cook I.A., Leuchter A.F., Morgan M., Witte E., Stubbeman W.F., Abrams M., et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002, 27:120-131.
9. Cook I.A., Leuchter A.F., Morgan M.L., Stubbeman W., Siegman B., Abrams M., et al. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. JPsychiatr Res 2005, 39:461-466.
10. Cook I.A., Hunter A.M., Gilmer W.S., Iosifescu D.V., Zisook S., Burgoyne K.S., et al. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. JClin Psychiatry 2013, 74:51-56.
11. Cook I.A., Hunter A.M., Korb A.S., Leuchter A.F. Do prefrontal midline electrodes provideunique neurophysiologic information in Major Depressive Disorder?. JPsychiatric Res 2014, 53:69-75.
12. Dresler M., Spoormaker V.I., Beitinger P., Czisch M., Kimura M., Steiger A., et al. Neuroscience-driven discovery and development of sleep therapeutics. Pharmacol Ther 2014, 141:300-334.
13. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Ann NY Acad Sci 1999, 877:614-637.
14. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry 2000, 48:813-829.
15. Gelenberg A.J., Chesen C.L. How fast are antidepressants?. JClin Psychiatry 2000, 61:712-721.
16. Gursky J.T., Krahn L.E. The effects of antidepressants on sleep: a review. Harv Rev Psychiatry 2000, 8:298-306.
17. Hobson J.A., Pace-Schott E.F. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 2002, 3:679-693.
18. Holsboer F. How can we realize the promise of personalized antidepressant medicines?. Nat Rev Neurosci 2008, 9:638-646.
19. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
20. Kirchheiner J., Nickchen K., Bauer M., Wong M.L., Licinio J., Roots I., et al. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 2004, 9:442-473.
21. Lauer C.J., Riemann D., Wiegand M., Berger M. From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 1991, 29:979-993.
22. Lauer C.J., Schreiber W., Holsboer F., Krieg J.C. In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry 1995, 52:145-153.
23. Leuchter A.F., Cook I.A., Lufkin R.B., Dunkin J., Newton T.F., Cummings J.L., et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage 1994, 1:208-219.
24. Leuchter A.F., Uijtdehaage S.H.J., Cook I.A., O'Hara R., Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res 1999, 90:125-140.
25. Leuchter A.F., Cook I.A., Narr K.L., Narr K.L., Toga A., Hunter A.M., et al. Biomarkers to predict antidepressant response. Curr Psychiatry Rep 2010, 12:553-562.
26. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997, 8:1057-1061.
27. Modell S., Ising M., Holsboer F., Lauer C.J. The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatry 2005, 58:694-699.
28. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., et al. Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin EEG Neurosci 2007, 38:78-81.
29. Murck H., Nickel T., Künzel H., Antonijevic I.A., Schill J., Zobel A., et al. State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology 2003, 28:348-358.
30. Nishida M., Hirai N., Miwakeichi F., Maehara T., Kawai K., Shimizu H., et al. Theta oscillation in the human anterior cingulate cortex during all-night sleep: an electrocorticographic study. Neurosci Res 2004, 50:331-341.
31. Nofzinger E.A., Reynolds C.F., Thase M.E., Frank E., Jennings J.R., Fasiczka A.L., et al. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 1995, 152:274-276.
32. Nofzinger E.A., Berman S., Fasiczka A., Miewald J.M., Meltzer C.C., Price J.C., et al. Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using [18F]-FDG PET. Psychiatry Res 2001, 106:95-111.
33. Olbrich S., Mulert C., Karch S., Trenner M., Leicht G., Pogarell O., et al. EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage 2009, 45:319-332.
34. Olbrich S., Arns M. EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response. Int Rev Psychiatry 2013, 25:604-618.
35. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001, 158:405-415.
36. Pizzagalli D.A. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011, 36:183-206.
37. Rechtschaffen A., Kales A.A. Amanual of Standardized terminology, Techniques and scoring system for sleep stages of Human subjects 1968, UCLA. Brain Information Service, Los Angeles.
38. Schmid D.A., Wichniak A., Uhr M., Ising M., Brunner H., Held K., et al. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin and leptin and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology 2006, 31:832-844.
39. Sonntag A., Rothe B., Guldner J., Yassouridis A., Holsboer F., Steiger A. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 1996, 4:1-13.
40. Steiger A., Kimura M. Wake and sleep EEG provide biomarkers in depression. JPsychiatr Res 2010, 44:242-252.
41. Souery D., Oswald P., Massat I., Bailer U., Bollen J., Demyttenaere K., et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. JClin Psychiatry 2007, 68:1062-1070.
42. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28-40.
43. Uhr M., Tontsch A., Namendorf C., Ripke S., Lucae S., Ising M., et al. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 2008, 57:203-209.
44. Zajecka J.M. Treating depression to remission. JClin Psychiatry 2003, 64:7-12.